Innate Pharma
IPHA
#8351
Rank
โ‚น14.43 B
Marketcap
โ‚น169.01
Share price
0.00%
Change (1 day)
-17.62%
Change (1 year)

EPS for Innate Pharma (IPHA)

EPS in 2022: -โ‚น66.74

According to Innate Pharma 's latest financial reports the company's current EPS (TTM) is -โ‚น66.74. In 2022 the company made an earnings per share (EPS) of -โ‚น66.74 a decrease over its 2021 EPS that were of -โ‚น63.80.

EPS history for Innate Pharma from 2005 to 2022

Annual EPS

Year EPS Change
2022-โ‚น66.744.6%
2021-โ‚น63.80-24.98%
2020-โ‚น85.04186.89%
2019-โ‚น29.64-707.12%
2018โ‚น4.88-105.35%
2017-โ‚น91.20-541.28%
2016โ‚น20.67-270.34%
2015-โ‚น12.13-70.03%
2014-โ‚น40.49390.66%
2013-โ‚น8.25-8.65%
2012-โ‚น9.03-57.03%
2011-โ‚น21.02-48.58%
2010-โ‚น40.87-40.32%
2009-โ‚น68.4924.76%
2008-โ‚น54.8922.34%
2007-โ‚น44.8716.95%
2006-โ‚น38.36-7.23%
2005-โ‚น41.36